EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Neuronal ALKAL2 and its ALK receptor contribute to the development of colitis-associated colorectal cancer

Mélissa Delanne-Cuménal, Manon Defaye, Améline Delanne-Cuménal, Mansoor Ahmed, Valerie Ho, Nasser S Abdullah, Mohamad Alhassoun, Kristofer Svendsen, Lukas Mager, Joseph Schlessinger iD, Simon Hirota, Christophe Altier iD

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2500632122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Mélissa Delanne-Cuménal und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N4N1, Canada. Hauptthemen laut MEDLINE: Anaplastic Lymphoma Kinase, Colorectal Neoplasms, Colitis-Associated Neoplasms, Colitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Government | Canadian Institutes of Health Research (CIHR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor-infiltrating nerves play a critical role in cancer progression and treatment resistance. Our recent work identified ALKAL2, a ligand for the Anaplastic Lymphoma Kinase (ALK) receptor, as a key mediator of inflammatory pain, with its expression significantly elevated in TRPV1+ sensory neurons during inflammation. Here, we explored the regulation of neuronal ALKAL2 in a colitis-associated colorectal cancer (CAC) model. We found that neuronal ALKAL2 is upregulated at early stages of CAC, which in turn activates ALK signaling in the colonic mucosa. Notably, treating mouse colonic organoids with exogenous ALKAL2 triggered ALK activation. In vivo, mice treated with the ALK inhibitor lorlatinib at the onset of colitis exhibited a remarkable 90% reduction in tumor burden without significantly affecting overall inflammation. Moreover, activating TRPV1+ neurons using DREADD technology exacerbated tumor growth, whereas silencing these neurons significantly reduced it. These findings reveal that TRPV1+ nociceptors drive CAC progression via the ALKAL2/ALK pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anaplastic Lymphoma KinaseColorectal NeoplasmsColitis-Associated NeoplasmsColitisAnimalsMiceTRPV Cation ChannelsHumansSignal TransductionNociceptorsNeuronsMice, Inbred C57BLDisease Models, Animal

Stichwörter der Autor:innen

anaplastic lymphoma kinase receptorcell signalingcolorectal cancerreceptor tyrosine kinase

Substanzen

Anaplastic Lymphoma KinaseTRPV Cation ChannelsTRPV1 protein, mouseAlk protein, mouse

Autor:innen und Institutionen

  • Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N4N1, Canada.
  • Department of Physiology and Pharmacology, Inflammation Research Network-Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB T2N4N1, Canada.
  • Department of Physiology and Pharmacology, Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB T2N4N1, Canada.
  • Department of Physiology and Pharmacology, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB T2N4N1, Canada.
  • Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, AB T2N4N1, Canada.
  • Department of Pharmacology, Yale University School of Medicine, New Haven, CT 0620.

ORCID-Profile: Joseph Schlessinger, Christophe Altier

Förderung

  • Canadian Government | Canadian Institutes of Health Research (CIHR)

Zitieren

APA

Delanne-Cuménal, M., Defaye, M., Delanne-Cuménal, A., Ahmed, M., Ho, V., Abdullah, N. S., Alhassoun, M., Svendsen, K., Mager, L., Schlessinger, J., Hirota, S., & Altier, C. (2025). Neuronal ALKAL2 and its ALK receptor contribute to the development of colitis-associated colorectal cancer. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2500632122

Vancouver

Delanne-Cuménal M, Defaye M, Delanne-Cuménal A, Ahmed M, Ho V, Abdullah NS, et al. Neuronal ALKAL2 and its ALK receptor contribute to the development of colitis-associated colorectal cancer. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2500632122

BibTeX
@article{DelanneCumnal2025,
  author = {Delanne-Cuménal, Mélissa and Defaye, Manon and Delanne-Cuménal, Améline and Ahmed, Mansoor and Ho, Valerie and Abdullah, Nasser S and Alhassoun, Mohamad and Svendsen, Kristofer and Mager, Lukas and Schlessinger, Joseph and Hirota, Simon and Altier, Christophe},
  title = {Neuronal ALKAL2 and its ALK receptor contribute to the development of colitis-associated colorectal cancer},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2500632122}
}
Kostenlos starten →